Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review-Reference-Cited by-同舟云学术

Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review

Published:2017-07-17 Issue:8 Volume:13 Page:843-857
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Van Herwaarden Noortje¹,Van Den Bemt Bart J.F.²³,Wientjes Maike H.M.¹,Kramers Cornelis⁴⁵,Den Broeder Alfons A.¹⁶

Affiliation:

1. Department of Rheumatology, Sint Maartenskliniek Nijmegen, The Netherlands

2. Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands

3. Department of Pharmacy, Radboudumc Nijmegen, The Netherlands

4. Department of Pharmacology-Toxicology, Radboudumc, Nijmegen, The Netherlands

5. Department of Internal Medicine, Radboudumc, Nijmegen, The Netherlands

6. Department of Rheumatology, Radboudumc, Nijmegen, the Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2017.1353602

Reference59 articles.

1. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

3. Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis

4. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

5. Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis;Seminars in Arthritis and Rheumatism;2023-12

2. Therapeutic drug monitoring of disease-modifying antirheumatic drugs in circulating leukocytes in immune-mediated inflammatory diseases;Inflammopharmacology;2023-05-09

3. The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study;Rheumatology;2022-12-20

4. Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review;RMD Open;2022-12

5. Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider;RMD Open;2022-06